Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

JF Rocha, A Falcão, A Santos, R Pinto, N Lopes… - European journal of …, 2014 - Springer
Background and objectives Opicapone is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor. The purpose of this study was to compare the levodopa …
被引用次数：80 相关文章

Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

J Rocha, A Falcão, A Santos, R Pinto… - … Journal of Clinical …, 2014 - search.proquest.com
Opicapone is a novel third generation catechol-O-methyltransferase (COMT) inhibitor. The
purpose of this study was to compare the levodopa pharmacokinetic profile throughout a day …

Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations.

JF Rocha, A Falcão, A Santos, R Pinto… - European Journal of …, 2014 - europepmc.org
Methods A randomized, double-blind, gender-balanced, parallel-group study was performed
in 4 groups of 20 healthy subjects each. Four subjects in each group received placebo …

Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

JF Rocha, A Falcão, A Santos, R Pinto, N Lopes… - European Journal of …, 2014 - infona.pl
Background and objectives Opicapone is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor. The purpose of this study was to compare the levodopa …
[PDF] academia.edu

[PDF][PDF] Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

JF Rocha, A Falcão, A Santos, R Pinto, N Lopes… - Eur J Clin …, 2014 - academia.edu
Background and objectives Opicapone is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor. The purpose of this study was to compare the levodopa …

Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations.

JF Rocha, A Falcão, A Santos, R Pinto… - … Journal of Clinical …, 2014 - search.ebscohost.com
Background and objectives: Opicapone is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor. The purpose of this study was to compare the levodopa …

[引用][C] Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

JF ROCHA, A FALCAO, A SANTOS… - European journal of …, 2014 - pascal-francis.inist.fr
Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily
levodopa administrations CNRS Inist Pascal-Francis CNRS Pascal and Francis …

Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

JF Rocha, A Falcão, A Santos, R Pinto, N Lopes… - 2014 - pubmed.ncbi.nlm.nih.gov
Background and objectives Opicapone is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor. The purpose of this study was to compare the levodopa …
[PDF] researchgate.net

[PDF][PDF] Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

JF Rocha, A Falcão, A Santos, R Pinto… - Eur J Clin …, 2014 - researchgate.net
Background and objectives Opicapone is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor. The purpose of this study was to compare the levodopa …
[PDF] academia.edu

[PDF][PDF] Effect of opicapone and entacapone upon levodopa pharmacokinetics during three daily levodopa administrations

JF Rocha, A Falcão, A Santos, R Pinto, N Lopes… - Eur J Clin …, 2014 - academia.edu
Background and objectives Opicapone is a novel third generation catechol-O-
methyltransferase (COMT) inhibitor. The purpose of this study was to compare the levodopa …